🔎 Trials Near Me

Home › Interstitial Lung Diseases › Florida › Orlando

Interstitial Lung Diseases clinical trials in Orlando, FL

9 studies for Interstitial Lung Diseases are looking for participants at sites in and around Orlando (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

RecruitingPhase 3
  • Clinical Research Specialists LLC - Kissimmee, Kissimmee · 16 mi away
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07540988

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

RecruitingPhase 3
  • Clinical Research Specialists LLC - Kissimmee, Kissimmee · 16 mi away
Ages 40 and older · All sexes · Updated Sep 30, 2026 · NCT07201922

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

RecruitingPhase 2
  • Eunix Clinical Research, Orlando
Ages 18 to 80 · All sexes · Updated Sep 29, 2026 · NCT05798923

A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)

RecruitingPhase 3
  • Clinical Research Site, Kissimmee · 16 mi away
Ages 18 to 85 · All sexes · Updated Sep 11, 2026 · NCT07816185

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

RecruitingPhase 2
  • Clinical Research Site, Kissimmee · 16 mi away
Ages 18 to 85 · All sexes · Updated Sep 2, 2026 · NCT07333183

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

RecruitingObservational study
  • Advent Health Medical Group Advanced Lung Disease, Orlando
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06388421

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

RecruitingObservational study
  • Advent Health, Orlando
Ages 18 to 80 · All sexes · Updated Jun 26, 2026 · NCT06129240

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

RecruitingPhase 2
  • Central Florida Pulmonary Group, P.A. (CFPG) - Downtown Orlando, Orlando
  • Florida Lung Asthma and Sleep Specialist, Celebration · 17 mi away
Ages 40 and older · All sexes · Updated Nov 12, 2025 · NCT05975983

About Interstitial Lung Diseases

Interstitial lung diseases are a group of diseases that inflame or scar the lungs. Breathing in particles (asbestosis, silicosis) causes some types.

More about Interstitial Lung Diseases on MedlinePlus

Interstitial Lung Diseases trials in other cities

Other studies in Orlando

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.